Current Clinical Trials
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: BMS
Indentifier #: NCT01285609
Title: CA184104 IDEate, Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab in Addition to Paclitaxel and Carboplatin Versus Placebo in Addition to Paclitaxel and Carboplatin in Subjects With Stage IV/Recurrent Non Small Cell Lung Cancer (NSCLC)
Department: Oncology
Diagnosis: Breast
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: NSABP
Indentifier #: NCT00769379
Title: NSABP B43, A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently With Radiation Therapy and Radiation Therapy Alone for Women With HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: BMS
Indentifier #: NCT01642004
Title: CA209017, An Open-label Randomized Phase III Trial of BMS-936558 versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
Department: Oncology
Diagnosis: Breast
Principal Investigator: Lynch MD, Cynthia A.
Sub-Investigator(s):
Sponsor: NSABP
Indentifier #: NCT01275677
Title: NSABP B47, A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women With Node- Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: BMS
Indentifier #: NCT01673867
Title: CA209057, An Open-Label Randomized Phase III Trial of BMS-936558 versus Docetaxel in Previously Treated Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)